Saturday, July 11, 2026

pharma · No medical condition. · Breast cancer

George Institute for

George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER

Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Sydney, NSW 2042, AU
Founded
1999
Employees
841
Programs
406
Drugs
522
Patents
0
Clinical program

A Phase I for Relapse/ refractory acute Leukemia

Phase 1 · other · Relapse/ refractory acute Leukemia

A Phase I for Relapse/ refractory acute Leukemia for Relapse/ refractory acute Leukemia is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
The George Institute
Phase
Phase 1
Modality
other
Indication
Relapse/ refractory acute Leukemia
Status
active
Trials
1